Through its wholly-owned subsidiary, Oxygen Working Capital (“OWC”) the company offers factoring and other commercial financing services to clients across Canada. Read More
Source link
SOLVE FSHD Portfolio Company Altay Therapeutics Closes $37 Million Series A Financing to Advance DX5057 for FSHD
“This financing is an important validation of Altay, of the potential of DX5057 and of what patient-focused, early-stage investment can make possible,” said Eva Chin, Ph.D., Executive Director of SOLVE…






